ALSO NOTED: Pfizer transfers HG in Germany; NICE reversal on Alimta; Barr gets copycat OK; and much more...

> Pfizer is transferring its German HQ from Berlin to Karlsruhe. Report

> The UK's NICE has reversed itself, calling for the use of Eli Lilly's Alimta in fighting asbestos-related cancer. Report

> The FDA has approved Barr's copycat version of Dostinex. Report

> InterMune has struck a new supply agreement on Actimmune. Report

And Finally... Medicare and insurers are paying billions of dollars for new therapies to treat atrial fibrillation, even though most of the therapies are unproven. Report